Max Healthcare Institute Share Price

    NSE
    0.00
    0.00 (0.00%)
    MAXHEALTH
    BUY

    1Y Annualised Return

    33.07%

    3Y Annualised Return

    49.91%

    The current prices are delayed, login or Open Demat Account for live prices.

    Max Healthcare Institute Stock Performance

    1W Return-0.29
    1Y Return30.08
    Today's Low1213.1
    Prev. Close1,243.60
    Mkt Cap (Cr.)1,18,183.89
    1M Return2.88
    3Y Return233.85
    52-Week High1314.3
    Open1,241.50
    PE Ratio156.53
    6M Return18.41
    Today's High1249.1
    52-Week Low836.6
    Face Value10

    Max Healthcare Institute Company background

    Founded in: 2001
    Managing director: Abhay Soi

    Founded in: 2001 Managing director: Abhay Soi

    Max Healthcare Institute Limited has grown into a major player in India's healthcare scene since its start in 2001. It wasn't always called that. At first, the company was named Infinitum Technologies Private Limited. But soon, big changes came its way. By June 28, 2002, the name had switched to Max Healthcare Institute Private Limited. And just a few months later, on October 18 of the same year, it transformed once more, this time becoming a public company known as Max Healthcare Institute Limited. Abhay Soi, the current Managing Director, leads the charge. His vision? Offering all-round healthcare. From simple doctor visits to high-tech treatments in top-notch hospitals, the company got it covered.

    Healthcare Services and Facilities

    Max Healthcare is all about serving up top-notch healthcare in India, especially in the northern regions. It’s pretty busy with a web of 13 healthcare centers, including big names like BLK and BNH Hospitals. These places emphasize specialized care for severe illnesses and conditions. The company is really good at things like cancer treatment, brain and nerve issues, heart health, bone and joint care, kidney health, and liver surgeries. Oh, and let's not forget its focus on weight loss surgeries, too!

    But Max Healthcare isn't just about hospitals. It’s branching out in cool ways with two special business units: MaxHome and MaxLab. What's MaxHome, you ask? It brings healthcare right to your doorstep. It covers everything from lab tests and pharmacy deliveries to physiotherapy and critical care nursing in your home.

    Then there's MaxLab, which makes lab services accessible beyond hospital walls. It’s teaming up with other places to manage lab work, ensuring quality pathology services are available everywhere.
    Geographical Presence and Global Expansion

    Max Healthcare's facilities are situated across several main Indian cities. Eight hospitals and five medical centers are concentrated in Delhi and the National Capital Region (NCR), while others are located in Mumbai, Mohali, Bathinda, and Dehradun. The company has also established a representative office in Nairobi, Kenya, under the moniker True Max Healthcare. This international presence aims to partner with local hospitals, conduct outpatient departments (OPDs), and engage with potential patients requiring medical visas and pre-travel preparations. The Nairobi office also plays a main role in building the Max Healthcare brand through participation in local events.

    Milestones and Developments

    Since its founding, Max Healthcare has marked several main milestones. In 2000, it opened its first Medcentre with outpatient services and day-care surgeries at Panchsheel Park. By 2002, facilities in Pitampura and Noida were inaugurated, marking Pitampura as the first ISO-certified hospital for high-end secondary care. In 2004, the company enhanced its service scope with advanced cardiac life support and air evacuation services at Max Heart Vascular Institute, Saket. This was followed by the opening of a multi-specialty tertiary care center in East Delhi’s Max Hospital, Patparganj in 2005, and a super specialty tertiary care facility at Max Super Speciality Hospital, Saket in 2006.

    More expansion occurred in 2009 with the relaunch of BLK Hospital as a multi-super specialty facility and partnerships with the government for developing greenfield super specialty hospitals in Punjab. The next decade saw a significant growth in North India through public-private partnerships, notably with Mohali and Bathinda hospitals, and the opening of Max Super Speciality Hospital in Dehradun in 2012.

    Innovative Healthcare Solutions

    Max Healthcare is all about raising the bar in medical technology and patient care. It’s constantly pushing the envelope, and it shows. Back in 2012, BLK Hospital took a big step by installing the first cyberknife VSI in the entire Asia-Pacific region. This was a huge leap for better diagnostic precision. Just a year later, by 2013, it started offering liver and kidney transplants. There were even remarkable surgeries, like separating conjoined twins from Nigeria.

    Max Healthcare constantly kept introducing cutting-edge services. Like in 2016 when it opened India’s very first oncology daycare center specifically for chemotherapy patients. It’s also rolled out cool initiatives such as the "Responder on Bike" program, aiming to get help to people faster. Plus, it’s set up the Max Centre for Liver and Biliary Sciences for specialized care.

    Corporate Expansion and Strategic Alliances

    Strategic acquisitions and alliances have been a key part of Max Healthcare's growth strategy. In 2015, the company got a controlling stake in Crosslay Remedies Limited (CRL), adding a 378-bed hospital to its portfolio. This expansion was followed in 2016 by the establishment of MaxHome, Max Lab, and new healthcare services dedicated to oncology and other specialties.

    Further corporate structuring occurred in 2020 when the National Company Law Tribunal approved a Composite Scheme of Amalgamation and Arrangement. This restructuring involved the merging of healthcare assets, making Max Healthcare the second-largest healthcare delivery chain in India based on income from healthcare services. Resultantly, Max Healthcare shares got listed on the BSE Limited and National Stock Exchange of India Limited (NSE) on August 21, 2020, a pretty big milestone for the company.

    Recent Developments and Future Outlook

    The company's growth continues to be quite strong, as proven by its activities in 2022 and 2023. In February 2022, Max Healthcare increased its bed capacity by 400 through a 26% stake acquisition in Eqova Healthcare Private Limited. This move was paired with an exclusive long-term operation and management agreement with Muthoot Hospitals Private Limited for a new hospital in Dwarka, New Delhi.

    Land acquisitions in Gurugram aimed at setting up two hospitals so as to increase the company's bed capacity in the NCR region by 1000 beds further underline its ambitious growth plans. In adherence to market and regulatory requirements, Kayak Investments Holding Pte. Limited, one of the company's promoters, had an open market sale, ensuring compliance with public shareholding norms.

    Also, with the unveiling of a 92-bedded oncology block at Max Super Speciality Hospital in Shalimar Bagh and cloud deployment initiatives at main locations, the company is at the forefront of healthcare innovation.

    Shareholding and Corporate Governance

    The corporate governance and shareholding structure of Max Healthcare has seen pretty big hanges over the years. The current promoters of Max Healthcare are Mr. Abhay Soi and Kayak Investments Holding Pte. Ltd. As per regulatory norms, the company has achieved the Minimum Public Shareholding (MPS) requirements, which marks the reclassification of certain promoters into the public shareholder category. The promoters such as Mr. Analjit Singh, Ms. Neelu Analjit Singh, and others have been reclassified as public shareholders, leaving Mr. Abhay Soi and Kayak Investments as the core promoters of the company.

    In the fast-evolving Indian healthcare sector, Max Healthcare continues to be a substantial player with a significant market presence. The dynamics of Max Healthcare’s operations can be contextualized with the company's public listing and share performance. Since being listed on major stock exchanges, the Max Healthcare share price has become a critical indicator of the company's market value and investor perception.

    Quick Overview

    Max Healthcare Institute Limited's journey from a private limited company to a big player in the Indian healthcare sector shows strategic growth, technological advancement, and commitment to healthcare excellence. With its pretty vast service offerings, strategic geographic presence, innovative healthcare solutions, and strong corporate governance, Max Healthcare is ready to continue its significant contribution to healthcare delivery in India and beyond.

    As of , Max Healthcare Institute share price is ₹1215.7. The stock opened at ₹1241.5 and had closed at ₹1243.6 the previous day. During today’s trading session, Max Healthcare Institute share price moved between ₹1,213.10 and ₹1,249.10, with an average price for the day of ₹1231.10. Over the last 52 weeks, the stock has recorded a low of ₹836.60 and a high of ₹1,314.30. In terms of performance, Max Healthcare Institute share price has increased by 18.4% over the past six months and has increased by 33.07% over the last year.

    Read More
    Max Healthcare Institute SIP Return Calculator

    Over the past

    1 year
    3 years
    Total Investment of ₹65,00,000
    Would have become ₹77,07,774 (+18.58%)
    Daily SIP of 25,000 would have become 77,07,774 in 1 year with a gain of 12,07,774 (+18.58%)
    View details of Market Depth

    Max Healthcare Institute Fundamental

    Market Cap (in crs)

    1,18,183.89

    Face Value

    10

    Turnover (in lacs)

    28,969.58

    Key Metrics

    Qtr Change %
    45.31% Gain from 52W Low
    12.1
    Dividend yield 1yr %
    Below industry Median
    0.2

    Max Healthcare Institute Key Financials

    View more
    Loading chart...
    Loading chart...
    Loading chart...
    Loading chart...
    Max Healthcare Institute Quarterly Revenue
    Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
    1909.74 Cr
    1868.31 Cr
    1707.46 Cr
    1542.95 Cr
    1422.9 Cr
    Max Healthcare Institute Yearly Revenue
    Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
    7184.1 Cr
    5584.09 Cr
    4701.84 Cr
    4058.82 Cr
    2619.41 Cr
    1107.11 Cr
    Max Healthcare Institute Quarterly Net Profit/Loss
    Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
    319 Cr
    238.8 Cr
    281.81 Cr
    236.27 Cr
    251.54 Cr
    Max Healthcare Institute Yearly Net Profit/Loss
    Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
    1075.88 Cr
    1057.64 Cr
    1103.51 Cr
    605.05 Cr
    -114.5 Cr
    12.91 Cr

    Max Healthcare Institute Result Highlights

    • Max Healthcare Institute Ltd reported a 22.8% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Mar (Q4FY25). On a year-on-year (YoY) basis, it witnessed a growth of 17.0%.

    • Its expenses for the quarter were down by 25.5% QoQ and up 18.7% YoY.

    • The net profit increased 5.3% QoQ and increased 0.2% YoY.

    • The earnings per share (EPS) of Max Healthcare Institute Ltd stood at 2.6 during Q4FY25.

      Read more

    Data Source: BSE, Company announcements

    The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

    Top Mutual Fund Invested in Max Healthcare Institute

    Promoter
    23.7%
    Foreign Institutions
    54.8%
    Mutual Funds
    12.5%
    Domestic Institutions
    17.4%
    Public
    4.1%
    Promoter
    23.7%
    Foreign Institutions
    54.7%
    Mutual Funds
    13.4%
    Domestic Institutions
    17.6%
    Public
    3.9%
    Promoter
    23.7%
    Foreign Institutions
    56.9%
    Mutual Funds
    11.7%
    Domestic Institutions
    15.6%
    Public
    3.8%
    Promoter
    23.7%
    Foreign Institutions
    57.3%
    Mutual Funds
    11.6%
    Domestic Institutions
    15.1%
    Public
    3.8%
    Promoter
    23.7%
    Foreign Institutions
    57%
    Mutual Funds
    12.2%
    Domestic Institutions
    15.4%
    Public
    3.9%
    Promoter
    23.8%
    Foreign Institutions
    57.3%
    Mutual Funds
    12.3%
    Domestic Institutions
    15%
    Public
    4%

    Max Healthcare Institute Technical Analysis

    Moving Averages Analysis
    0.00
    Current Price
    Bullish Moving Averages
    7
    Bearish Moving Averages
    9
    5Day EMA
    1,240.90
    10Day EMA
    1,249.20
    12Day EMA
    1,250.10
    20Day EMA
    1,245.90
    26Day EMA
    1,239.40
    50Day EMA
    1,210.40
    100Day EMA
    1,164.20
    200Day EMA
    1,093.60
    5Day SMA
    1,247.20
    10Day SMA
    1,255.00
    20Day SMA
    1,258.20
    30Day SMA
    1,239.80
    50Day SMA
    1,207.30
    100Day SMA
    1,140.00
    150Day SMA
    1,129.20
    200Day SMA
    1,096.30
    Delivery & Volume
    Loading chart...

    Delivery & Volume

    PeriodCombined Delivery VolumeNSE+BSE Traded Volume
    Day Rs
    1623382 Rs
    2401364 Rs
    Week Rs
    984963 Rs
    1583763 Rs
    Month Rs
    1555894 Rs
    2286414 Rs
    1,225.97
    Pivot
    Resistance
    First Resistance
    1,238.83
    Second Resistance
    1,261.97
    Third Resistance
    1,274.83
    Support
    First Support
    1,202.83
    Second support
    1,189.97
    Third Support
    1,166.83
    Relative Strength Index
    45.27
    Money Flow Index
    43.06
    MACD
    10.64
    MACD Signal
    19.41
    Average True Range
    34.25
    Average Directional Index
    18.38
    Rate of Change (21)
    4.53
    Rate of Change (125)
    15.79
    Name
    Holding Percent
    SBI Mutual Fund
    1.54
    Motilal Oswal Mutual Fund
    1.39
    Canara Robeco Mutual Fund
    1.28
    Axis Mutual Fund
    1.01
    New World Fund Inc
    5.33
    Government Of Singapore
    5.07
    Smallcap World Fund, Inc
    3.31
    Monetary Authority Of Singapore
    1.43
    Government Pension Fund Global
    1.14
    Vanguard Total International Stock Index Fund
    1.1
    Kotak Funds - India Midcap Fund
    1.06
    Hdfc Life Insurance Company Limited
    1.06
    Nps Trust- A/C ICICI Prudential Pension Fund Scheme E - Tier I
    1.04

    Max Healthcare Institute Latest News

    15 JUL 2025 | Tuesday

    Max Healthcare Institute Ltd - 543220 - Announcement under Regulation 30 (LODR)-Change in Management

    11 JUL 2025 | Friday

    Max Healthcare Institute Ltd - 543220 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

    08 JUL 2025 | Tuesday

    Max Healthcare Institute Ltd - 543220 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    View More

    Max Healthcare Institute Share Price FAQs

    Max Healthcare Institute share price in the past 1-year return was 30.08. The Max Healthcare Institute share hit a 1-year low of Rs. 836.6 and a 1-year high of Rs. 1314.3.

    The market cap of Max Healthcare Institute is Rs. 118183.89 Cr. as of 18/7/2025.

    The PE ratios of Max Healthcare Institute is 156.53 as of 18/7/2025.

    The PB ratios of Max Healthcare Institute is 14.26 as of 18/7/2025

    The Mutual Fund Shareholding in Max Healthcare Institute was 12.54% at the end of 18/7/2025.

    You can easily buy Max Healthcare Institute shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

    The 52-week high and low of Max Healthcare Institute share price is ₹1314.3 and ₹836.6 as of 18/7/2025.

    Please be aware that Max Healthcare Institute stock prices are subject to continuous fluctuations due to various factors.

    Popular Stocks
    65.06
    -1.20 (-1.81%)
    133.84
    -1.07 (-0.79%)
    680.25
    -1.45 (-0.21%)
    2,596.10
    -20.50 (-0.78%)
    157.39
    -1.85 (-1.16%)
    376.00
    -5.45 (-1.43%)
    162.37
    +2.47 (+1.54%)
    257.20
    -2.45 (-0.94%)
    394.75
    -9.45 (-2.34%)
    407.90
    -5.55 (-1.34%)
    Top Gainers
    266.95
    +6.35 (+2.44%)
    942.00
    +18.70 (+2.03%)
    162.37
    +2.47 (+1.54%)
    246.31
    +2.44 (+1.00%)
    2,472.20
    +23.10 (+0.94%)
    Top Losers
    1,099.30
    -60.50 (-5.22%)
    645.50
    -19.95 (-3.00%)
    394.75
    -9.45 (-2.34%)
    739.50
    -12.30 (-1.64%)
    1,901.00
    -28.90 (-1.50%)
    Open Demat Account
    +91 -

    Open Demat Account
    +91 -